Skip to main content

Special Announcement

Liver Health Programme

Liver Health Programme

Liver Health Programme (the Programme) is a screening service designed for people at high risk for liver cancer. The Programme adopts a 3-biomarker approach for blood analysis with enhanced sensitivity* in detection of hepatocellular carcinoma (HCC). In conjunction with liver imaging, the Programme provides more information for liver cancer surveillances.


Programme Features

  • Suitable for high risk groups including hepatitis B/C carriers, patients of cirrhosis, and individuals with other risk factors such as obesity, smoking and diabetes
  • Two biomarkers, AFP-L3 and PIVKA-II, are added in the blood analysis to supplement the conventional approach of testing a single biomarker, AFP with improved sensitivity for HCC detection  and help to detect HCC in the early stages*
  • Non-invasive ultrasonography for detecting liver abnormalities
  • Supported by our multi-disciplinary team to offer subsequent diagnostic and treatment services for patients in need


Programme Details and Fee

Programme Items

  • Doctor Consultation: includes one pre-test and one post-test consultation

  • Blood Analysis: 3 biomarkers - AFP, AFP-L3 and PIVKA-II

  • Liver Imaging: Ultrasonography 

Fee (HKD)



Booking and Enquiry: 3946 6188


*German cohort; Best J et al., The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early-stage hepatocellular carcinoma; Z Gastroenterol 2016; 54: 1296-1305

The information provided by the blood analysis with using 3-biomarker approach is designed for health screening purposes only and it is not intended to diagnose, treat, or prevent any diseases or medical conditions. The result of the blood analysis is provided for reference only and is not intended to replace medical examination.